Early research (Phase 1)Study completedNCT04408963What this trial is testingTrial to Evaluate CAP256V2LS in Healthy AdultsWho this might be right forHIV National Institute of Allergy and Infectious Diseases (NIAID) 10
Not applicableStudy completedNCT04033887What this trial is testingEvaluation Study of RDTs Detecting Antibodies Against HCVWho this might be right forHepatitis C Foundation for Innovative New Diagnostics, Switzerland 1,710
Testing effectiveness (Phase 2)Study completedNCT03721510What this trial is testingA Phase 1/2a Study of PGT121, VRC07-523LS and PGDM1400 Monoclonal Antibodies in HIV-uninfected and HIV-infected AdultsWho this might be right forHIV/AIDS International AIDS Vaccine Initiative 19
Early research (Phase 1)Study completedNCT00503347What this trial is testingBavituximab Repeat-Dose Trial in Patients Co-Infected With Chronic Hepatitis C Virus and Human Immunodeficiency VirusWho this might be right forHepatitis C VirusHiv Infections Peregrine Pharmaceuticals 24
Large-scale testing (Phase 3)Study completedNCT00000135What this trial is testingStudies of the Ocular Complications of AIDS (SOCA)--Monoclonal Antibody CMV Retinitis Trial (MACRT)Who this might be right forHIV InfectionsCytomegalovirus Retinitis Johns Hopkins Bloomberg School of Public Health 209
Testing effectiveness (Phase 2)Study completedNCT00784147What this trial is testingDose-Response Study of Ibalizumab (Monoclonal Antibody) Plus Optimized Background Regimen in Patients With HIV-1Who this might be right forHIV TaiMed Biologics Inc. 113
Testing effectiveness (Phase 2)Looking for participantsNCT04319367What this trial is testingA Randomised Placebo Controlled Trial of ART Plus Dual Long-acting HIV-specific Broadly Neutralising Antibodies (bNAbs).Who this might be right forHIV/AIDS and Infections Imperial College London 72
Testing effectiveness (Phase 2)Looking for participantsNCT05719441What this trial is testingA Clinical Trial of Combination HIV-Specific Broadly Neutralizing Monoclonal Antibodies Combined With ART Initiation During Acute HIV Infection to Induce HIV RemissionWho this might be right forAcute HIV Infection National Institute of Allergy and Infectious Diseases (NIAID) 48
Large-scale testing (Phase 3)Study completedNCT00003595What this trial is testingCombination Chemotherapy With or Without Monoclonal Antibody Therapy in Treating Patients With Previously Untreated HIV-Associated Non-Hodgkin's LymphomaWho this might be right forLymphoma National Cancer Institute (NCI) 120
Not applicableStudy completedNCT06368453What this trial is testingEvaluate the Performance, Usability, and Result Interpretation of INSTI® HIV Self-TestWho this might be right forHuman Immunodeficiency Virus I InfectionHuman Immunodeficiency Virus II Infection bioLytical Laboratories 1,728
Early research (Phase 1)Not Yet RecruitingNCT07392372What this trial is testingA Clinical Trial Investigating the Safety and Biological Activity of the Antibody BNT351 in Adults Living Without and With HIVWho this might be right forHIV -1 Infection BioNTech SE 61
Early research (Phase 1)Study completedNCT00027365What this trial is testingAn Investigational Combination Vaccine Given to People Who Are Not Infected With HIVWho this might be right forHIV Infections National Institute of Allergy and Infectious Diseases (NIAID) 84
Early research (Phase 1)Ended earlyNCT03571204What this trial is testingCombination Therapy With 3BNC117 and 10-1074 in HIV-Infected IndividualsWho this might be right forHIV National Institute of Allergy and Infectious Diseases (NIAID) 27
Early research (Phase 1)Study completedNCT01993706What this trial is testingStudy of the Safety and Pharmacokinetics of a Human Monoclonal Antibody, VRC-HIVMAB060-00-AB (VRC01), Administered Intravenously or Subcutaneously to Healthy AdultsWho this might be right forHIV InfectionMonoclonal Antibody, HumanHIV Antibodies+2 more National Institute of Allergy and Infectious Diseases (NIAID) 29
Early research (Phase 1)Study completedNCT02165267What this trial is testingEvaluating the Safety and Drug Levels of an Antibody Against HIV in Healthy, HIV-Uninfected AdultsWho this might be right forHIV Infections National Institute of Allergy and Infectious Diseases (NIAID) 88
Early research (Phase 1)Study completedNCT00001105What this trial is testingThe Safety and Effectiveness of Human Monoclonal Antibody, F105, in the Treatment of HIVWho this might be right forHIV Infections National Institute of Allergy and Infectious Diseases (NIAID) 8
Testing effectiveness (Phase 2)Study completedNCT00886964What this trial is testingHepatitis B Vaccination (HBV) in HIV Infected ChildrenWho this might be right forHIV Infections The HIV Netherlands Australia Thailand Research Collaboration 80
Testing effectiveness (Phase 2)Active Not RecruitingNCT05729568What this trial is testingTeropavimab and Zinlirvimab in Combination With Capsid Inhibitor Lenacapavir in Virologically Suppressed Adults With HIV-1 InfectionWho this might be right forHIV Infection Gilead Sciences 83
Early research (Phase 1)Active Not RecruitingNCT06006546What this trial is testingThe Study of Immunization in People Living With HIV Undergoing an ATI for Elicitation of VRC01-lineage AntibodiesWho this might be right forChronic HIV Infection National Institute of Allergy and Infectious Diseases (NIAID) 35
Testing effectiveness (Phase 2)Looking for participantsNCT06812494What this trial is testingVRC07-523LS, PGT121.414.LS, and PGDM1400LS Broadly Neutralizing Monoclonal Antibodies Given Intravenously in Adult Participants Without HIVWho this might be right forHIV National Institute of Allergy and Infectious Diseases (NIAID) 200